ROBERT HERSHBERG Insider Trading
Get free email notifications about insider trading for ROBERT HERSHBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HERSHBERG. ROBERT HERSHBERG is a Sr. VP & Chief Medical Officer in DENDREON CORP ($DNDN) and a Director in NanoString Technologies Inc ($NSTG) and a Director in Adaptive Biotechnologies Corp ($ADPT) and a Director in RECURSION PHARMACEUTICALS, INC. ($RXRX).
Address: 3005 FIRST AVENUE SEATTLE 98121 WA
Companies in which ROBERT HERSHBERG is an Insider
Adaptive Biotechnologies Corp
Trading Symbol: ADPTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT HERSHBERG: Director
Holdings: 3,504 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DENDREON CORP
Trading Symbol: DNDNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HERSHBERG: Sr. VP & Chief Medical Officer
Holdings: 15,724 shares
Latest Transaction: Jan 23 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NanoString Technologies Inc
Trading Symbol: NSTGIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT HERSHBERG: Director
Holdings: 7,410 shares
Current Value: $140,864
Latest Transaction: Jun 17 2021
$NSTG Market Capitalization: $400.76M
$NSTG Previous Close: $19.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RECURSION PHARMACEUTICALS, INC.
Trading Symbol: RXRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT HERSHBERG: Director
Holdings: 0 shares
Latest Transaction: Apr 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT HERSHBERG
Sentiment: All, ADPT, DNDN, NSTG, RXRX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 0.00 | 3,890 | 0 | 3,890 | |
Jun 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.00 | 5,520 | 0 | 0 | |
Jun 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 0.00 | 5,520 | 0 | 7,410 | 1.9 K to 7.4 K (+292.06 %) |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 2.22 | 525,000 | 1,165,500 | 525,000 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 2.22 | 525,000 | 1,165,500 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 18.00 | 12,500 | 225,000 | 12,500 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 18.00 | 12,500 | 225,000 | 0 |